查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197327

颅内支架市场 - 增长、趋势和预测 (2023-2028)

Intracranial Stents Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，颅内支架市场预计将以 7.59% 的复合年增长率註册。

COVID-19 大流行影响了颅内支架市场的增长。 由于 COVID-19 相关措施导致择期手术延迟对颅内支架市场产生了负面影响，尤其是在 2020 年，由于资源转移给 COVID-19 患者，大多数手术被取消或推迟。。 世界范围内的外科手术显着减少。 例如，英国外科杂誌报导称，2020 年 5 月，印度每週取消约 48,728 台手术，估计 12 週内取消了 585,000 台。 然而，随着 COVID-19 限制措施的解除、手术的重新开放以及因事故导致的就诊和住院人数增加，所研究的市场有望在未来 2-3 年内从 COVID-19 的下滑中恢復过来。

中风患病率上升、对微创颅内手术的需求增加以及老年人口增加等因素正在推动市场增长。 例如，根据世界中风组织 2022 年的报告，全球每年报告的新中风病例超过 1220 万例。 根据同一数据，中风患病率在 70 岁及以上人群中最高 (67%)，其次是 15-49 岁人群 (22%)。 因此，中风的高负担，加上老年人口的增加，预计会增加对支架取栓治疗的需求，以去除形成大脑的血栓。 预计这将在预测期内刺激市场增长。

此外，根据 2022 年 10 月在埃及神经病学、精神病学和神经外科杂誌上发表的一篇文章，颅内动脉粥样硬化性狭窄 (ICAS) 是全球中风的主要原因之一，患病率因人口统计而异，据说是亚裔、西班牙裔和美国人。 根据同一来源，ICAS 占每年发生的大约 900,000 例中风和短暂性脑缺血发作 (TIA) 的 10%，这些患者每年有 15% 的复发机会。我在这里。 此外，在亚洲国家，归因于 ICAS 的卒中比例 (33-50%) 高于美国和西方国家 (10-15%)。 因此，由于 ICAS 的负担更大，预计亚洲国家的人们患中风的风险更高。 预计这将增加对颅内支架置入术的需求，推动市场增长。

此外，越来越多的公司和大学开发技术先进的支架也促进了市场增长。 例如，2022 年 1 月，MicroPort NeuroTech Limited 在 PROMISE 研究中招募了第一名患者，这是一项评估颅内动脉瘤治疗的 Rebridge 颅内可视化支架上市前临床试验。 在此背景下，市场有望在预测期内扩大。 然而，缺乏熟练的专业人员使用颅内支架和颅内支架的脑血管并发症可能会阻碍预测期内颅内支架市场的增长。

颅内支架市场趋势

在预测期内，脑动脉瘤部分预计将继续保持最高复合年增长率

预计在预测期内，脑动脉瘤部分的颅内支架市场将出现显着增长。 该领域增长的驱动因素是脑动脉瘤发病率上升以及患这种疾病的高危老年人口不断增加。

人口老龄化更容易患脑动脉瘤，这有望刺激市场增长。 例如，2021 年 10 月发表在 Annals of Medicine 上的一篇论文观察到，未破裂脑动脉瘤的发生率在 60 岁以上的患者中最高。 此外，2021 年 9 月发表在 NLM 上的一篇论文证实，未破裂的动脉瘤在老年女性中很常见，在 60 至 69 岁的日本女性中患病率最高为 14.5%。。 根据世界卫生组织公布的数据，到2022年10月，到2021年全球约有10亿人将达到或超过65岁。 此外，预计到 2030 年将增加到 14 亿。 这样，随着老年人口的增加，脑动脉瘤在人群中的负担较大，因此预计脑部手术清除血栓的需求会增加。 预计这将推动市场增长。

此外，大脑和神经系统疾病领域研发活动的增加、大脑相关治疗方式的增加以及产品发布和批准的增加也将在预测期内加速市场增长。 例如，2022年2月，微创神经科技有限公司自主研发的Neurohawk支架取栓器获得中国国家药品监督管理局（NMPA）的上市许可。 该装置是一种自膨胀式血栓支架取栓器，用于血管内有创血栓切除术，用于清除血管内的大血栓。 因此，由于上述因素（例如脑动脉瘤和相关风险因素的增加以及产品批准的增加），预计研究部门在预测期内将显着增长。

北美有望在预测期内主导颅内支架市场

由于人口中颅内狭窄和脑动脉瘤的发病率上升以及发达的医疗保健系统的存在等因素，预计在预测期内北美的颅内支架市场将增长。预计将占据主导地位。 此外，对微创手术的需求不断增加以及技术先进的颅内支架的不断增加预计将推动该地区的市场增长。

神经系统疾病、特发性颅内高压和脑动脉瘤患病率上升是推动市场增长的关键因素。 例如，根据脑动脉瘤基金会公布的2022年数据，美国每年约有650万人患有未破裂的脑动脉瘤。 年破裂率约为每 10 万人 8-10 例。 根据同一数据，美国每年约有 30,000 人患有脑动脉瘤破裂。 因此，预计患有脑动脉瘤的人数众多将增加对颅内支架的需求并推动市场增长。

此外，根据 2022 年 5 月发表的一篇论文，颅内主动脉瓣狭窄 (ILAS) 是美国缺血性中风的重要原因。 因此，该国中风相关疾病的负担越来越重，预计这将推动该国对用于中风相关手术的颅内支架的需求。

此外，采用筹款和合作伙伴关係等各种业务战略的公司越来越多，预计也将推动市场增长。 例如，2021 年 8 月，Fluid Biotech 在种子轮融资中筹集了 470 万美元。 合同製造商将使用这笔资金来计划生产启动、监管里程碑的完成，以及用于治疗脑动脉瘤的革命性支架（聚合物金属混合流体转向脑支架）的首次人体植入。用于参与 因此，由于上述因素，预计市场在预测期内将显着增长。

颅内支架市场竞争对手分析

这个市场竞争激烈，世界上主要的公司製造了大部分颅内支架。 拥有更多研究资金和更好的分销系统的市场领导者正在市场中站稳脚跟。 此外，随着亚太地区获得认可，小型企业也出现了。 这也推动了市场的增长。 市场参与者包括 Penumbra, Inc、Medtronic Plc、Stryker Corporation、Boston Scientific Corporation、Johnson & Johnson Services, Inc、Terumo Corporation、Cook Group、MicroPort Scientific 和 Acandis GmbH。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 对微创颅内手术的需求不断增加
    • 中风患病率上升和老年人口增加
  • 市场製约因素
    • 缺乏熟练的颅内支架手术专业人员
    • 与颅内支架术相关的脑血管并发症
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 自扩张支架
    • 球囊扩张支架
    • 支架辅助弹簧圈栓塞
  • 通过使用
    • 颅内狭窄
    • 脑动脉瘤
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Penumbra, Inc.
    • Medtronic Plc
    • Stryker Corporation
    • Boston Scientific Corporation
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation
    • Cook Group
    • MicroPort Scientific
    • Acandis GmbH
    • Balt Extrusion
    • MicroPort Scientific Corporation
    • phenox GmbH

第7章 市场机会与今后动向

简介目录
Product Code: 67454

The intracranial stents market is expected to register a CAGR of 7.59% over the forecast period.

The COVID-19 pandemic has impacted the growth of the intracranial stents market. The delays in performing elective procedures due to COVID-19-related measures had adversely affected the intracranial stents market, especially in 2020, as most of the procedures were canceled or postponed due to the diversion of resources toward the COVID-19 patients. There was a significant decrease in surgical procedures worldwide. For instance, according to the report of the British Journal of Surgery, in May 2020, around 48,728 surgical procedures per week were canceled in India which is estimated around 585,000 surgical procedures for 12 weeks. However, with the released COVID-19 restrictions, resumed surgical procedures and increased hospital visits and admissions due to accidents, the studied market is expected to recover from the decline of COVID-19 in the next two-three years.

Factors such as the rising prevalence of stroke, increasing demand for minimally invasive intracranial surgeries, and the growing geriatric population are boosting the market growth. For instance, as per the World Stroke Organization report of 2022, more than 12.2 million new stroke cases are reported each year, globally. In addition, as per the same source, the prevalence of stroke is highest among people aged 70 years and above (67%), followed by people aged between 15-49 years (22%). Thus, the high burden of stroke coupled with the increasing geriatric population is expected to increase the demand for stent-retriever thrombectomy treatment for removing blood clots forming the brain. This is anticipated to fuel the market growth over the forecast period.

Additionally, as per an article published in the Egyptian Journal of Neurology, Psychiatry, and Neurosurgery, in October 2022, intracranial atherosclerotic stenosis (ICAS) is one of the main causes of stroke worldwide and its prevalence varies depending on the demographic, with Asians, Hispanics,n Americans. In addition, as per the same source, ICAS affects 10% of the estimated 900,000 strokes or transient ischemic episodes (TIAs) yearly, and the probability of recurrence in these patients is 15% annually. Also, the Asian populations have a greater rate of strokes (33-50%) that can be attributed to ICAS as compared to the United States and western nations (10-15%). Thus, the high burden of ICAS among the population is expected to increase their risk of experiencing a stroke. This in turn is anticipated to fuel the demand for intracranial stenting procedures, hence propelling the market growth.

Furthermore, the rising company and university activities in developing technologically advanced stents are also contributing to the market growth. For instance, in January 2022, MicroPort NeuroTech Limited enrolled the first patient in the PROMISE Study, a pre-market clinical study for the Rebridge Intracranial Visualized Stent evaluating the treatment of an intracranial aneurysm. Therefore, owing to the aforementioned factors the studied market is expected to grow over the forecast period. However, the lack of skilled professionals for operating using intracranial stents and cerebrovascular complications related to intracranial stenting are likely to impede the growth of the intracranial stent market over the forecast period.

Intracranial Stents Market Trends

Brain Aneurysm Segment Expects to Register a Highest CAGR Over the Forecast Period

The brain aneurysm segment is expected to witness significant growth in the intracranial stenting market over the forecast period. The factors attributing to the segment growth are the rising incidence of brain aneurysms and the increasing geriatric population who are at greater risk of having this disease.

The increasing geriatric population is more prone to develop brain aneurysms which are anticipated to fuel the market growth. For instance, as per an article published in the Annals of Medicine, in October 2021, it has been observed that the incidence of unruptured cerebral aneurysms is highest in patients over 60 years. Also, from an article published in NLM, in September 2021, it has been observed that unruptured aneurysms were more common in elderly women with a peak prevalence of 14.5% in Japanese women aged between 60-69 years. Also, according to the data published by WHO, in October 2022, about 1 billion people living globally were aged 65 years or above, in 2021. In addition, this number is projected to increase to 1.4 billion by 2030. Thus, the high burden of brain aneurysms among the population along with the growing elderly population is expected to raise the need for brain surgeries to remove blood clots. This is anticipated to propel the market growth.

Moreover, growing research and development activities in the field of brain and neurological disorders and the increasing number of therapeutic procedures associated with the brain as well as rising product launches and approvals are also expected to implicitly accelerate the growth of the market during the forecast period. For instance, in February 2022, MicroPort NeuroTech Limited received marketing approval from China's National Medical Products Administration (NMPA) for its self-developed Neurohawk Stent Thrombectomy Device. The device is a self-expandable clot stent retriever used in endovascular invasive thrombectomy procedures to remove large clots in blood vessels. Thus, owing to the aforementioned factors such as the rising burden of brain aneurysms and associated risk factors as well as increasing product approvals, the studied segment is expected to grow significantly during the forecast period.

North America is Expected to Dominate the Intracranial Stents Market Over the Forecast Period

North America is expected to dominate the intracranial stent market over the forecast period owing to the factors such as the rising incidences of intracranial stenosis and brain aneurysms among the population, and the presence of a well-structured healthcare system. Also, the increasing demand for minimally invasive procedures as well as growing technologically advanced intracranial stents is expected to increase the market growth in the region.

The growing prevalence of neurological disorders, idiopathic intracranial hypertension, and brain aneurysm is the key factor driving the market growth. For instance, according to 2022 data published by the Brain Aneurysm Foundation, about 6.5 million people in the United States have an unruptured brain aneurysm, annually. The annual rate of rupture is approximately about 8 - 10 per 100,000 people. According to the same source, about 30,000 people in the United States suffer a brain aneurysm rupture each year. Thus, the high number of people suffering from brain aneurysms is expected to increase the demand for intracranial stents hence boosting the market growth.

Additionally, as per the article published in May 2022, intracranial large artery stenosis (ILAS) is an important contributor to ischemic stroke in the United States. Thus, the burden of diseases related to stroke is increasing in the country and this is expected to drive the demand for intracranial stents used for stroke-related surgeries in the country.

Furthermore, the rising company focus on adopting various business strategies such as financing, collaborations, and others are also expected to increase the market growth. For instance, in August 2021, Fluid Biotech raised USD 4.7 million in the seed funding round. This fund is used to engage contract manufacturers to initiate production, complete regulatory milestones, and plan for the first-in-human implantation of its innovative stent, a hybrid polymer-metal flow-diverting brain stent, for treating brain aneurysms. Thus, owing to the aforementioned factors, the studied market is expected to grow significantly during the forecast period.

Intracranial Stents Market Competitor Analysis

The market is fairly competitive with the presence of global key players manufacturing the majority of intracranial stents. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow. Some of the key companies in the market are Penumbra, Inc., Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Terumo Corporation, Cook Group, MicroPort Scientific and Acandis GmbH among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Minimally Invasive Intracranial Surgeries
    • 4.2.2 Rising Prevalence of Stroke and Increasing Geriatric population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professional for Operating using Intracranial Stents
    • 4.3.2 Cerebrovascular Complications Related to Intracranial Stenting
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Self-expanding Stents
    • 5.1.2 Balloon Expanding Stents
    • 5.1.3 Stent-assisted Coil Embolization
  • 5.2 By Application
    • 5.2.1 Intracranial Stenosis
    • 5.2.2 Brain Aneurysm
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Penumbra, Inc.
    • 6.1.2 Medtronic Plc
    • 6.1.3 Stryker Corporation
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Johnson & Johnson Services, Inc.
    • 6.1.6 Terumo Corporation
    • 6.1.7 Cook Group
    • 6.1.8 MicroPort Scientific
    • 6.1.9 Acandis GmbH
    • 6.1.10 Balt Extrusion
    • 6.1.11 MicroPort Scientific Corporation
    • 6.1.12 phenox GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS